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We applied a combination of molecular cytogenetic methods, including comparative genomic hybridization (CGH), spectral
karyotyping (SKY), and ﬂuorescence in situ hybridization (FISH), to characterize the genetic aberrations in eight widely used
cervical cancer (CC) cell lines. CGH identiﬁed the most frequent chromosomal losses including 2q, 3p, 4q, 6q, 8p, 9p, 10p,
13q, and 18q; gains including 3q, 5p, 5q, 8q, 9q, 11q, 14q, 16q, 17q, and 20q; and high-level chromosomal ampliﬁcation at 3q21,
7p11, 8q23–q24, 10q21, 11q13, 16q23–q24, 20q11.2, and 20q13. Several recurrent structural chromosomal rearrangements,
including der(5)t(5;8)(p13;q23) and i(5)(p10); deletions affecting chromosome bands 5p11, 5q11, and 11q23; and breakpoint
clusters at 2q31, 3p10, 3q25, 5p13, 5q11, 7q11.2, 7q22, 8p11.2, 8q11.2, 10p11.2, 11p11.2, 14q10, 15q10, 18q21, and 22q11.2
were identiﬁed by SKY. We detected integration of HPV16 sequences by FISH on the derivative chromosomes involving bands
18p10 and 18p11 in cell line C-4I, 2p16, 5q21, 5q23, 6q, 8q24, 10, 11p11, 15q, and 18p11 in Ca Ski, and normal chromosome
17 at 17p13 in ME-180. FISH analysis was also used further to determine the copy number changes of PIKA3CA and MYC. This
comprehensive cytogenetic characterization of eight CC cell lines enhances their utility in experimental studies aimed at gene
discovery and functional analysis. © 2003 Wiley-Liss, Inc.
INTRODUCTION
Cervical cancer (CC) is the second most common
gynecologic malignancy in the world in both inci-
dence and mortality. Infection with human papil-
loma virus (HPV) is considered an initiating factor
in CC carcinogenesis (Brisson et al., 1994). Al-
though 95% of the patients with precancerous le-
sions harbor HPV, only a small fraction of the cases
eventually progress to invasive cancer (zur Hausen,
2000). Therefore, HPV infection alone was consid-
ered insufﬁcient for malignant conversion, suggest-
ing a role of other genetic changes in the develop-
ment of CC. Identiﬁcation of such genetic
alterations is critical for our understanding of the
molecular basis of CC development. Thus, cell
lines provide an excellent and continuous source of
tumor material for such a genetic characterization.
Conventional cytogenetic analysis has identiﬁed
several recurrent structural chromosomal changes
involving chromosomes 1, 3, 5, 17, and the X chro-
mosome in CC (Atkin, 1997). A precise cytogenetic
characterization in CC was not feasible because of
the difﬁculty in identifying complex chromosome
changes in primary tumors. Recently, however,
several molecular cytogenetic techniques, such as
ﬂuorescence in situ hybridization (FISH), compar-
ative genomic hybridization (CGH), and spectral
karyotyping (SKY)/multicolor-FISH (m-FISH),
have been used to illustrate the precise genetic
aberrations in tumor genomes (Kallioniemi et al.,
1992; Schro¨ck et al., 1996; Speicher et al., 1996;
Singh et al., 2001; Rao et al., 2002). Several cell
lines derived from patients with CC are available
that provide a renewable source of material for
genetic analysis and that have been used in various
studies. Therefore, complete cytogenetic charac-
terization of CC lines will provide useful genetic
information for multiple studies.
Here, we characterized eight widely used CC
cell lines by G-banding, CGH, SKY, and FISH,
and we present their comprehensive molecular cy-
togenetic proﬁling. These cell lines have previ-
ously not been subjected to detailed cytogenetic
characterization. We identiﬁed several chromo-
somal regions that may be important in tumor de-
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velopment. Losses of 2q and gains of 3q, 5p, and 8q
were signiﬁcant. Notably, the combined approach
of CGH, SKY, and FISH analysis deﬁned the ori-
gin of 2q loss and gain of 3q, 5p, and 8q. In addi-
tion, we identiﬁed several ampliﬁed chromosomal
regions: 3q21, 7p11, 8q23–q24, 10q21, 11q13,
16q23–q24, 20q11.2, and 20q13.1. Through FISH,
we have also shown the integration of HPV16 se-
quences in three of the eight cell lines. This com-
prehensive characterization of these cell lines aug-
ments their utility in investigations targeted at
gene discovery and functional analysis in CC.
MATERIALS AND METHODS
Cell Lines
The cell lines (Ca Ski, C-33A, C-4I, HT-3, ME-
180, MS751, SiHa, and SW756) were obtained from
the American Type Culture Collection (ATCC,
Manassas, VA), and were grown according to the
supplier’s recommendations. Chromosome prepa-
rations and G-banded karyotypes were made by
standard protocols. Clonal chromosomal abnormal-
ities identiﬁed by G-banding were described ac-
cording to An International System for Human
Cytogenetic Nomenclature (ISCN, 1995). Clonal-
ity was described by detection of two cells with the
same structural abnormality or chromosomal gain
and loss of the same chromosome in three cells.
The metaphase spreads were aged at room temper-
ature for 1 week for SKY. The consensus karyotype
was generated for each cell line on the basis of
G-banding and SKY analysis.
CGH
High molecular weight DNA was isolated from
cell lines and normal placenta by standard methods
and subjected to CGH according to a previously
published method, with some modiﬁcations (Kal-
lioniemi et al., 1992). The metaphase preparations
were captured and processed by use of the Quan-
titative Image Processing System (Applied Imag-
ing, Santa Clara, CA).
SKY
The cocktail of human chromosome paints was
obtained from Applied Spectral Imaging (ASI,
Carlsbad, CA). Hybridization and detection were
carried out according to the manufacturer’s proto-
col, with slight modiﬁcations. Chromosomes were
counterstained with 4,6-diamidino-2-phenylindole
(DAPI). For each case, at least ﬁve metaphase cells
were analyzed by SKY. Images were acquired with
a SD200 Spectra cube (ASI) mounted on a Zeiss
Axioplan II microscope (Zeiss, Jena, Germany) by
use of a custom-designed optical ﬁlter (SKY-1;
Chroma Technology, Brattleboro, VT) and ana-
lyzed by use of SKY View 1.2 software (ASI).
The breakpoints on the SKY-painted chromo-
somes were determined by comparison of corre-
sponding inverted-DAPI banding of the same chro-
mosome and by comparison with the G-banded
karyotype for each cell line. By this method, we
were able to deﬁne the breakpoints on add and der
chromosomes, but were unable to assign the pre-
cise breakpoints of chromosomal segments from
partner chromosomes that generated the add or der
chromosomes. A breakpoint was considered to be
recurrent if it was identiﬁed in two or more cases
(Rao et al., 1998). A breakpoint cluster was deﬁned
as the occurrence of four or more breakpoints in the
same chromosomal band.
FISH
FISH was performed to identify the HPV16 in-
tegration sites and copy number changes of MYC
(8q24) and PIKA3CA (3q26.3) in eight CC cell
lines. The plasmid containing HPV16 sequences
and the BAC clone (386M7) containing PIKA3CA
was labeled by nick translation with Spectrum Red/
Spectrum Green (Vysis, Downers Grove, IL). The
digoxigenin-labeled MYC probe was obtained from
Ventana (Tucson, AZ). Hybridization and detec-
tion were performed according to the manufac-
turer’s protocols.
RESULTS
DNA Copy Number Changes Identiﬁed by CGH
The most frequent chromosomal losses included
1p (38%), 2q (100%), 3p (62%), 4q (88%), 6q (63%),
8p (75%), 9p (38%), 10p (63%), 10q (38%), 11p
(38%), 11q (38%), 13q (75%), and 18q (88%); and
gains included 1p (38%), 3q (50%), 5p (63%), 5q
(38%), 7p (63%), 7q (63%), 9q (88%), 11q (50%),
14q (50%), 15q (38%), 16q (50%), 17q (63%), 19q
(50%), 20p (25%), 20q (88%), and Xq (38%) (Fig.
1A).
Figure 1. A: Ideograms showing DNA copy number changes iden-
tiﬁed by CGH in the cell lines. Thin vertical lines on either side of the
ideogram indicate losses (left) and gains (right) of the chromosomal
region. High-level ampliﬁcations are shown as thick lines (right). B:
Ideograms showing all of the breakpoints noted in the cell lines identi-
ﬁed by SKY (inverted-DAPI) in combination with G-banding ( repre-
sents translocation breakpoint, F represents deletion breakpoint,
represents duplication breakpoint). The number of breakpoints in
each chromosome that were identiﬁed by SKY/G-banding, but could
not precisely be assigned to a chromosomal band, are noted in the box
on top of the chromosome.
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Figure 1.
High-level ampliﬁcation was detected in eight
chromosomal sites in seven cell lines at 3q21,
7p11.2, 8q23–q24, 10q21, 11q13, 16q23–q24,
20q11.2, and 20q13.1. Recurrent ampliﬁcations
were noted in two sites at 7p11 (Ca Ski and MS751)
and 11q13 (MS751 and HT-3). Non-recurrent am-
pliﬁcations were noted at 3q21 (SiHa), 8q23–q24
(Ca Ski), 10q21 (ME-180), 16q23–q24 (SiHa),
20q11.2 (SW756), and 20q13.1 (C-33A).
SKY Analysis
A total of 116 translocations, 28 deletions, three
duplications, and an insertion were identiﬁed by
SKY in the eight cell lines. Recurrent deletions
affecting chromosomal bands were noted at 5p11
(Ca Ski, SW756), 5q11 (Ca Ski, MS751, SW756),
and 11q23 (HT-3, MS751). Table 1 summarizes
the karyotypes of the cell lines generated by SKY/
G-banding. One reciprocal translocation was noted
[t(X;10)(q25;q24) in C-33A] and a recurrent trans-
location [der(5)t(5;8) (p13;q23)] was noted in Ca
Ski and C-4I. Robertsonian translocations involv-
ing der(14;15)(q10;q10) in Ca Ski, der(14;14)(q10;
q10) in HT-3, and der(21;21)(q10;q10) in SiHa
were identiﬁed. Translocations involving whole
chromosomal arms were identiﬁed in two cell lines:
TABLE 1. Combined G-Banded and SKY/Inverted DAPI Karyotypes of Eight Cervical Cancer Cell Lines
Cell line Karyotype




14)(p11.2;?), der(11)t(11;14) (p11;q22)t(11;13)(q13;?) t(13;15)(?;q21), del(12)(q11), 13,del(13)(q?),
14,der(15)t(6;15)(?;q26),der(14;15)(q10;q10),i(16)(q10),del(16)(q11),der(18)t(12;18)(q11;q11),



































der(13)t(13;13)(p11;q14),der(14)t(14;20)(p11;p11),15,der(21)t(5;21) (?;?),der(21) t(9;21) (q22;
q22) [cp 5]
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der(8;22)(p10;q10) and der(12;15)(p10;q10) in ME-
180 and der(6;13)(p10;q10) and der(16;19) (p10;
q10) in HT-3. Six isochromosomes were noted:
i(X)(q10) in MS751; i(3)(q10) in ME-180; i(5)(p10)
in C-4I, SW756, and SiHa; i(12)(p10) in SW756;
i(16)(q10) in Ca Ski; and i(18)(p10) in C-4I, of
which i(5)(p10) is recurrent.
SKY/G-banding identiﬁed a total of 232 break-
points in rearranged chromosomes, with another 79
assigned to chromosomes on the basis of the iden-
tiﬁcation of chromosomal segments attached to or
inserted into add or der chromosomes, but whose
speciﬁc breakpoints could not be determined.
Overall, recurring breaks (two or more) were noted
in 51 sites. The breakpoint clusters (four or more)
were seen at 2q31, 3p10, 3q25, 5p13, 5q11, 7q11.2,
7q22, 8p11.2, 8q11.2, 10p11.2, 11p11.2, 14q10,
15q10, 18q21, and 22q11.2 (Fig. 1B).
Comparison of CGH and SKY Analysis
There was a good concordance between the
number of genomic imbalances identiﬁed by CGH
and unbalanced structural aberrations identiﬁed by
SKY. An example of the comparison is depicted in
Figure 2, which displays a loss of 2q (Ca Ski and
C-4I) and 11q (Ca Ski) and loss and gain of 3p and
3q (ME-180) and 5p and 5q (Ca Ski).
An isochromosome for the short arm of chromo-
some 5 [i(5)(p10)] was noted by SKY in C-4I,
SW756, and SiHa. The corresponding CGH pro-
ﬁles showed only a gain of chromosome arm 5p and
no loss of 5q. This may be attributable to the
translocation of 5q chromosomal material to other
chromosomes in the genome. The loss of Xp and
gain of Xq in cell line MS751 and loss of 16p and
gain of 16q in Ca Ski can be correlated with the
presence of i(X)(q10) and i(16)(q10), respectively.
SKY identiﬁed i(12)(p10) in SW756, but the corre-
sponding CGH proﬁles were normal; this discrep-
ancy may be ascribed to the low abundance of this
clone in the tumor genome.
The partial or total loss of 2q was identiﬁed by
CGH in all cell lines analyzed in the present study.
The loss of 2q coincides with the presence of
unbalanced structural rearrangements: der(2)t(2;
7)(?;p15)del(2)(q21) in C33-A, der(2)t(2;22)(q?31;
q11) in MS751, der(2)t(2;10)(q23;q22) in SiHa
and SW756, del(2)(q34) in C-4I, and del(2)(q33)
and der(2)t(2;9)(q?31;p?) in HT-3. Both deletion
[del(2)(q11)] and unbalanced structural rearrange-
Figure 2. A: Partial CGH karyotypes for chromosome 2 (Ca Ski, C-4I), 11 (Ca Ski), 3 (ME-180), and 5 (Ca
Ski) (left) and corresponding ratio proﬁles (right) showing loss of 2q, 11q, and 3p and gain of 3q. The vertical red
and green bars on the right of the ideogram indicate the threshold values of 0.80 and 1.20 for loss and gain,
respectively. B: Partial spectral karyotypes (classiﬁed images) of del(2q), del(2p), and der(2) in Ca Ski; del (2q) in
C-4I; der(11) in Ca Ski; del(3p) and der(3) in ME-180; and del(5p), del (5q), and der(5) in Ca Ski.
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ment [der(2) t(2;7)(q31;q22)] affecting 2q were
noted in cell line Ca Ski. In cell line ME-180, CGH
detected a loss of 2q, but the corresponding SKY
analysis failed to show any aberration. This dis-
crepancy may be ascribed to the limitation of sam-
pling size by SKY.
In the majority of cases, the chromosomal ampli-
ﬁcation results from the unbalanced translocations
material from one region to the other chromosomes
in the genome except for SIHA, where it displayed
the translocation, der(16)t(7;16)(q?;p11), and dupli-
cation of the 16q21q24 region. However, the am-
pliﬁcation at 10q21 in ME-180 and 11q13 in MS751
was visible only by CGH.
FISH Analysis
We detected integration of HPV16 sequences in
C-4I, Ca Ski, and ME-180 by FISH (Fig. 3). The
HPV16 integration was noted at 18p10 on
i(18)(p10) and at 18p11 on ins(18;14) (q21;q21q24)
in C-4I, and on normal chromosome 17 at 17p13 in
ME-180. In Ca Ski, HPV16 was integrated at 8q24
on der(X)t(X;8)(p11;p11), at 2p16 on del(2)(p22–
p24), at 5q21 and 5q23 on der(5)t(5;8)(p13;q23),
at 6q? on der(6)t(6;9)(p11;?), at 11p11 on
der(11)t(11;14)(p11;q22) and der(11)t(11;14)(p11.2;
?)t(11;13)(q13;?)t(13;15)(?;q21), at 18p11 on der(18)-
t(12;18)(q11;q11), at 15q? on der(18)t(15;18)(?;q11),
and at 10? on der(21)t(10;21)(?;p10) (Table 2 and
Fig. 3). The HPV16 and MYC signals were de-
tected as closely spaced signals on der(X)t(X;
8)(p11;p11)(p13;q23) in Ca Ski. On the basis of
ﬂuorescent signal intensity, we estimated the
HPV16 copy number to be two to seven copies in
Ca Ski and two to four copies in C-4I.
Because we identiﬁed recurrent gains at 3q and
8q by CGH, we performed FISH analysis to esti-
mate copy numbers in interphase nuclei and meta-
phase spreads through use of PIK3CA (3q26.3) and
MYC (8q24) as probes (Table 2). The distribution
of copy number for MYC ranged from two to six
copies, with more than ﬁve copies being noted in
Ca Ski, ME-180, MS751, and SiHa. In the ME-180
cell line, we identiﬁed der(5)t(5;8)(p13;q23) by
SKY, but FISH analysis identiﬁed this as a cryptic
duplication of MYC on the der(5) chromosome
(Fig. 3). This was consistent with the increased
copy number identiﬁed by CGH at 8q23–q24.1. By
use of PIK3CA (3q26.3) as a probe, FISH analysis
revealed a copy number increase in C-4I (three to
ﬁve copies), Ca Ski (two to four copies), and ME-
180 (two to three copies). These cell lines exhib-
ited gain of chromosome arm 3q by CGH.
DISCUSSION
We report here a comprehensive molecular cy-
togenetic description of eight CC cell lines by
G-banding, SKY, CGH, and FISH. CGH identiﬁed
the most frequent chromosomal losses including
2q, 3p, 4q, 6q, 8p, 9p, 10p, 13q, and 18q; and gains
including 3q, 5p, 5q, 8q, 9q, 11q, 14q, 16q, 17q, and
20q. The DNA copy number changes identiﬁed in
this study are consistent with previously published
CGH results for primary tumors (Heselmeyer et al.,
1996; Dellas et al., 1999; Kirchhoff et al., 1999;
Allen et al., 2000; Umayahara et al., 2002). High-
level chromosomal ampliﬁcations at 3q21, 7p11,
8q23–q24, 10q21, 11q13, 16q23–q24, 20q11.2, and
20q13.1 were noted in seven of the eight cell lines.
An increased copy number for 3q was noted in
four of the eight cell lines, and the common region
mapped to 3q26–q27. The 3q gain was identiﬁed
in a diverse group of tumors including head and
neck, cervix, lung, and esophagus, and it has been
shown to associate with a progression from high-
grade CIN to invasive CC (Heselmeyer et al.,
1996). Although previous studies have identiﬁed
several candidate genes on 3q26–q27, controversy
still exists regarding the gene(s) that are the target
of ampliﬁcation in CC. The PIK3CA locus, which
encodes a catalytic subunit of phosphatidylinositol
3-kinase, has been implicated as a candidate onco-
gene at 3q26 in carcinomas of the cervix, ovary, and
head and neck (Shayesteh et al., 1999; Ma et al.,
2000; Singh et al., 2001). We recently showed that
the negative effect of TP53 induction on cell sur-
vival involves the transcriptional inhibition of
PIK3CA that is independent of PTEN activity in
squamous cell carcinomas (Singh et al., 2002). An-
other gene, eIF-5A2, a member of the eukaryotic
initiation factor, which plays a role in translation
initiation, has been implicated as a candidate on-
cogene in ovarian cancer (Guan et al., 2001). Gains
of 5p were noted in ﬁve of eight cell lines studied.
This is suggestive of the presence of i(5)(p10) in
the tumor genome and is consistent with previ-
ously published cytogenetic studies (Atkin, 1997).
The telomerase reverse transcriptase (TERT) that
maps to 5p15 has been shown to control the telom-
erase activity by an expression of its catalytic com-
ponent. The TERT gene has been shown to be a
putative oncogene and was ampliﬁed in several
solid tumors, including cervical cancer (Greider,
1999; Zhang et al., 2002).
The loss of 2q was noted in 100% of the cell
lines, and the common region of deletion was
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Figure 3. Metaphase spreads from Ca Ski, C-4I, and ME-180 hybridized with SKY painting probes,
HPV16, and MYC probes. For each image from left to right are spectral classiﬁed images (A), FISH images
with HVP16 integration sites (B), and corresponding DAPI (C) and MYC signals (D). The integrated HPV16
sites are numbered in all metaphase spreads. Inset: Magniﬁed image of duplicated MYC in the ME-180 cell
line.
mapped to the 2q33–q36 region. SKY analysis also
conﬁrms the deletions as unbalanced structural re-
arrangements affecting the 2q region in seven of
the eight cell lines. These data strongly suggest
that this region harbors a tumor-suppressor gene(s).
We recently identiﬁed two common regions of de-
letions at 2q34–q35 and 2q36.3–q37.1 by high-
resolution deletion mapping studies (data not
shown). Other frequently deleted chromosomal re-
gions were 1p, 3p, 4p, 4q, 6q, 7q, 8p, 11p, 11q, 13q,
17p, 17q, 18q, 19p, and 19q. Some of these regions
(e.g., 3p, 4q, 5p, 6p, and 11p) were previously
shown to be deleted by loss of heterozygosity stud-
ies (Atkin, 1997; Luft et al., 1999; Pulido et al.,
2000; Chatterjee et al., 2001).
SKY analysis allowed the identiﬁcation of novel
breakpoints and recurrent translocations. Previous
cytogenetic studies in primary tumors and cell lines
identiﬁed several recurrent changes involving chro-
mosomes 1, 3, 5, 11, 17, and the X chromosome
(Atkin, 1997). The recurrent chromosomal rear-
rangements identiﬁed by SKY were translocation
der(5)t(5;8)(p13;q23), i(5)(p10), and deletions af-
fecting chromosomal bands 5p11, 5q11, and 11q23.
SKY identiﬁed several breakpoint clusters at 2q31,
3p10, 3q25, 5p13, 5q11, 7q11.2, 7q22, 8p11.2,
8q11.2, 10p11.2, 11p11.2, 14q10, 15q10, 18q21, and
22q11.2. Further, characterization of genes in the
breakpoint clusters may provide clues for under-
standing the biology and clinical behavior of CC.
CC is shown to associate with HPV infection,
particularly the high-risk types HPV16 and HPV18
(Canavan and Doshi, 2000). It has been established
that the oncogenic HPV viral proteins E6 and E7
interact with and inactivate the tumor-suppressor
proteins p53 and pRb1, thereby initiating a malig-
nant transformation (zur Hausen, 2000). The HPV
integration was found in a limited number of CC
cell lines or primary tumors at normal or abnormal
chromosomes. Recent molecular cytogenetic char-
acterization of the HeLa cell line revealed HPV18
integration on normal chromosome 8 (8q24) and
two derivative chromosomes involving the 8q24
band (Macville et al., 1999). In the present study,
we noted HPV16 integration on normal chromo-
some 17 at 17p13 in the ME-180 cell line and two
derivative chromosomes involving chromosome
bands 18p10 and 18p11 in C-4I. In cell line Ca Ski,
HPV integration was observed on one derivative
chromosome involving the 8q24 band and another
eight derivative chromosomes involving 2p16,
5q21, 5q23, 6q, 10, 11p11, 15q, and 18p11. This
strongly suggests that the genomic reorganization is
caused by HPV viral integration in cervical cancer.
This is consistent with previously published corre-
lation studies between the breakpoints in chromo-
somal rearrangements and HPV integration sites in
cervical cancer (De Braekeleer et al., 1992).
In conclusion, we report here the precise and
detailed characterization of eight frequently used





HPV statuscPIK3CAa MYC a
Ca Ski 2–4 (3q25–q29) 6 (8q21.3–q24.3) 8q24 on der(X)t(X;8)(p11;p11) HPV16
2p16 on del(2)(p22–p24)





18p11 on der(18)t(12;18) (q11;q11)
15q? on der(18)t(15;18)(?;q11)
10? on der(21)t(10;21)(?p10)
C-33A 2 2–4 None Negative
C-4I 3–5 (3q26–q29) 2–3 18p10 on i(18)(p10) HPV18
18p11 on ins(18;14)(q21;q21q24)
HT-3 2 2 (8q23–q24) None Negative
ME-180 2–3 (3q) 4–6 (8q23) 17p13 on 17 HPV39
MS751 2 3–6 (8q) None HPV18
SiHa 2 (3q21–q23) 3–5 (8q24) None HPV16
SW756 2 3–5 (8q) None No information
aGains identiﬁed by CGH are presented in parentheses.
bHPV16 integration breakpoints are in bold.
cSource: American Type Culture Collection (ATCC).
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CC cell lines by a combination of molecular cyto-
genetic methods, including CGH, SKY, and FISH.
This comprehensive genetic characterization fur-
ther augments experimental studies aimed at gene
discovery.
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